secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0001493152-24-007444
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO George Ng presents at Winter Wrap-Up MicroCap Rodeo Conference, Feb 20, 2024
--------------------------------------------------------------------------------

- Presentation furnished as Exhibit 99.1; no financial results or guidance provided.
- Presentation available on Processa's website under Investors section.
- Filing contains no material new information beyond the conference presentation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224007444/0001493152-24-007444-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224007444/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-007444

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer